Personalized cancer therapy assessment
UCSD Profile Related Evidence Determining Individualized Cancer Therapy (UCSD PREDICT)
This study is trying to see how personalized cancer treatments affect patients' responses and side effects by looking at their medical records and genetic information.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 7 Years and up |
| Sex | All |
| Sponsor | University of California, San Diego Academic / other |
| Locations | 3 sites (La Jolla, California and 2 other locations) |
| Trial ID | NCT02478931 on ClinicalTrials.gov |
What this trial studies
This study aims to investigate how personalized cancer therapy affects patient responses and side effects by analyzing medical records and treatment outcomes. It includes both retrospective and prospective components, examining molecular profiling results to understand the predictive value of genetic testing on treatment efficacy. Optional research tests on biological samples will help identify biomarkers that may indicate how patients respond to therapies. The study will evaluate various patient outcomes, including tumor response, treatment failure, survival rates, and toxicity levels.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients who are willing to provide informed consent and have undergone or will undergo molecular profiling as part of their treatment.
Not a fit: Patients who are unable to provide informed consent or those not undergoing any form of molecular testing may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective and tailored cancer treatments based on individual genetic profiles.
How similar studies have performed: Other studies have shown promise in personalized cancer therapy approaches, indicating potential for success in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Must be willing to provide informed consent, parent permission, or assent Exclusion Criteria: * Subjects unable to give informed consent, parent permission, or assent
Where this trial is running
La Jolla, California and 2 other locations
- UCSD Moores Cancer Center — La Jolla, California, United States (Recruiting)
- Eisenhower Medical Center, Lucy Curci Cancer Center — Rancho Mirage, California, United States (Recruiting)
- Rady Children's Hospital, San Diego — San Diego, California, United States (Recruiting)
Study contacts
- Principal investigator: Shumei Kato, MD — University of California, San Diego
- Study coordinator: Lee Suzanna, MPH
- Email: sml012@health.ucsd.edu
- Phone: (858) 534-1306
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.